Business · 14/11/1994Updated: 10/18/2026 · 1 min read
FDA Extends Comment Periods for General Biologics and Licensing Regulations
Summary
The Food and Drug Administration (FDA) is extending the comment period for two documents related to the review of biological regulations until February 13, 1995, to allow for additional public input and comment at an upcoming meeting.
Original source language: Federal Register — Health and Human ServicesOpen original release →